What does Dr. Sara Buys - Anesthesie do?

Dr. Sara Buys - Anesthesie is a specialist medical practice in Affligem. Private Limited, started on 12 February 2021, 1 establishment.

What is the address of Dr. Sara Buys - Anesthesie?

The registered office of Dr. Sara Buys - Anesthesie is located at Blakmeers 35, 1790 Affligem.

Is Dr. Sara Buys - Anesthesie still active?

Yes. According to the CBE (31 October 2026) Dr. Sara Buys - Anesthesie is active, legal situation “Normale toestand”, started on 12 February 2021.

Is Dr. Sara Buys - Anesthesie registered on Peppol?

Yes, Dr. Sara Buys - Anesthesie is registered on the Peppol network with ID 0208:0763553415.

What is the enterprise number of Dr. Sara Buys - Anesthesie?

The enterprise number of Dr. Sara Buys - Anesthesie is BE0763553415.

When was Dr. Sara Buys - Anesthesie founded?

Dr. Sara Buys - Anesthesie was founded on 12 February 2021.

Who are the directors of Dr. Sara Buys - Anesthesie?

According to the 2025 annual accounts, the directors of Dr. Sara Buys - Anesthesie are: Sara Buys.

Is Dr. Sara Buys - Anesthesie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 February 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Sara Buys - Anesthesie make in 2025?

Dr. Sara Buys - Anesthesie posted a profit after taxes of € 343,799 in financial year 2025.

What is the revenue of Dr. Sara Buys - Anesthesie?

As a small company, Dr. Sara Buys - Anesthesie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 434,375.

Dr. Sara Buys - Anesthesie (Private Limited) - Affligem

Dossier Dr. Sara Buys - Anesthesie, printed on 31 October 2026 from databakkes.be/en/0763553415/dr-sara-buys-anesthesie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Sara Buys - Anesthesie from Affligem, company number BE0763553415, closed financial year 2025 with a result of € 343,799 after tax. For that financial year Dr. Sara Buys - Anesthesie recorded a gross margin of € 434,375 and equity of € 48,147. Compared with financial year 2024, the result moved from € 325,443 to € 343,799. Profitable, and profit is growing. The buffer shrank hard: equity is 91 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on March 23, 2026.

What it is worth Shrank hard

€ 48,147

▼ 91% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 343,799

▲ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 308,380

▲ € 291,826 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 834,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 6,869

▼ 63% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 33,460 Gross margin 2022: € 33,460 First fiscal year in the series	€ 214,720 Gross margin 2023: € 214,720 ▲ € 181,260 vs 2022 (€ 33,460) Favourable step	€ 429,163 Gross margin 2024: € 429,163 ▲ 100% vs 2023 (€ 214,720) Favourable step	€ 434,375 Gross margin 2025: € 434,375 ▲ 1% vs 2024 (€ 429,163) Favourable step	▲ 1%
Profit after taxes	€ 25,310 Profit after taxes 2022: € 25,310 First fiscal year in the series	€ 164,078 Profit after taxes 2023: € 164,078 ▲ € 138,768 vs 2022 (€ 25,310) Favourable step	€ 325,443 Profit after taxes 2024: € 325,443 ▲ 98% vs 2023 (€ 164,078) Favourable step	€ 343,799 Profit after taxes 2025: € 343,799 ▲ 6% vs 2024 (€ 325,443) Favourable step	▲ 6%
Equity	€ 48,827 Equity 2022: € 48,827 First fiscal year in the series	€ 212,904 Equity 2023: € 212,904 ▲ € 164,078 vs 2022 (€ 48,827) Favourable step	€ 538,348 Equity 2024: € 538,348 ▲ 153% vs 2023 (€ 212,904) Favourable step	€ 48,147 Equity 2025: € 48,147 ▼ 91% vs 2024 (€ 538,348) Unfavourable step	▼ 91%
Total debts	€ 33,326 Total debts 2022: € 33,326 First fiscal year in the series	€ 78,598 Total debts 2023: € 78,598 ▲ 136% vs 2022 (€ 33,326) Unfavourable step	€ 25,206 Total debts 2024: € 25,206 ▼ 68% vs 2023 (€ 78,598) Favourable step	€ 265,020 Total debts 2025: € 265,020 ▲ € 239,814 vs 2024 (€ 25,206) Unfavourable step	▲ € 239,814
Cash	€ 78,088 Cash 2022: € 78,088 First fiscal year in the series	€ 287,500 Cash 2023: € 287,500 ▲ 268% vs 2022 (€ 78,088) Favourable step	€ 16,554 Cash 2024: € 16,554 ▼ 94% vs 2023 (€ 287,500) Unfavourable step	€ 308,380 Cash 2025: € 308,380 ▲ € 291,826 vs 2024 (€ 16,554) Favourable step	▲ € 291,826
Retained profit	€ 44,827 Retained profit 2022: € 44,827 First fiscal year in the series	€ 208,904 Retained profit 2023: € 208,904 ▲ € 164,078 vs 2022 (€ 44,827) Favourable step	€ 534,348 Retained profit 2024: € 534,348 ▲ 156% vs 2023 (€ 208,904) Favourable step	€ 44,147 Retained profit 2025: € 44,147 ▼ 92% vs 2024 (€ 534,348) Unfavourable step	▼ 92%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 834,000 Dividend 2025: € 834,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 82,153 Balance sheet total 2022: € 82,153 First fiscal year in the series	€ 291,503 Balance sheet total 2023: € 291,503 ▲ 255% vs 2022 (€ 82,153) Unchanged	€ 563,554 Balance sheet total 2024: € 563,554 ▲ 93% vs 2023 (€ 291,503) Unchanged	€ 313,167 Balance sheet total 2025: € 313,167 ▼ 44% vs 2024 (€ 563,554) Unchanged	▼ 44%

Key figures of Dr. Sara Buys - Anesthesie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Sara Buys - Anesthesie?

What happened at Dr. Sara Buys - Anesthesie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 23, 2026 New annual accounts for financial year 2025: profit of € 343,799 (▲ 6% vs 2024). Source: NBB ↗
Feb 12, 2021 New establishment in Gent. KBO
Feb 12, 2021 Start of the company according to the CBE. KBO

In short

From € 25,310 profit in 2022 to € 343,799 profit in 2025.

Paid € 267,654 in corporate taxes since 2022.

Best year ever: 2025, with € 343,799 profit.

Paid out € 834,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Sara Buys

Dr. Sara Buys - Anesthesie

Behind Dr. Sara Buys - Anesthesie is Sara Buys.

Directors

According to the 2025 annual accounts

Sara Buys

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Blakmeers 35

1790 Affligem

2.313.855.420

Muinkkaai 35

9000 Gent

Active since 12 February 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0763.553.415
VAT number: BE 0763.553.415
Registered office: Blakmeers 35, 1790 Affligem
Names & denominations: Dr. Sara Buys - Anesthesie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 12 February 2021
Peppol: Active · Active since 22 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗